lomefloxacin has been researched along with Complication, Postoperative in 4 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5% in the lomefloxacin group and from 94% to zero in the chloramphenicol group; rates of hyperemia decreased from 100% to zero in both groups." | 9.13 | Postoperative lomefloxacin 0.3% prophylaxis in strabismus surgery. ( Axer-Siegel, R; Bagan, J; Ehrlich, R; Friling, R; Goldenberg-Cohen, N; Hasanreisoglu, M; Snir, M, 2008) |
| "Lomefloxacin has the economic advantage of an oral route of administration compared to the parenteral route of cefotaxime for prophylaxis in transurethral genitourinary procedures." | 6.67 | Prevention of urinary tract infection and bacteremia following transurethral surgery: oral lomefloxacin compared to parenteral cefotaxime. ( Berger, NS; Crawford, ED; Davis, MA; Donohue, RE, 1992) |
| "5% in the lomefloxacin group and from 94% to zero in the chloramphenicol group; rates of hyperemia decreased from 100% to zero in both groups." | 5.13 | Postoperative lomefloxacin 0.3% prophylaxis in strabismus surgery. ( Axer-Siegel, R; Bagan, J; Ehrlich, R; Friling, R; Goldenberg-Cohen, N; Hasanreisoglu, M; Snir, M, 2008) |
| " This study was designed to evaluate two dosage regimens of a new difluoroquinolone, lomefloxacin, for prevention of postoperative bacteriuria following VLAP." | 5.07 | Lomefloxacin prophylaxis in visual laser ablation of the prostate. ( Costa, FJ, 1994) |
| "Lomefloxacin has the economic advantage of an oral route of administration compared to the parenteral route of cefotaxime for prophylaxis in transurethral genitourinary procedures." | 2.67 | Prevention of urinary tract infection and bacteremia following transurethral surgery: oral lomefloxacin compared to parenteral cefotaxime. ( Berger, NS; Crawford, ED; Davis, MA; Donohue, RE, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Snir, M | 1 |
| Hasanreisoglu, M | 1 |
| Friling, R | 1 |
| Goldenberg-Cohen, N | 1 |
| Ehrlich, R | 1 |
| Bagan, J | 1 |
| Axer-Siegel, R | 1 |
| Costa, FJ | 1 |
| Derevianko, II | 1 |
| Khodyreva, LA | 1 |
| Avdoshin, VL | 1 |
| Andriukhin, MI | 1 |
| Gabliia, MIu | 1 |
| Crawford, ED | 1 |
| Berger, NS | 1 |
| Davis, MA | 1 |
| Donohue, RE | 1 |
4 trials available for lomefloxacin and Complication, Postoperative
| Article | Year |
|---|---|
Postoperative lomefloxacin 0.3% prophylaxis in strabismus surgery.
Topics: Administration, Topical; Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Child | 2008 |
Lomefloxacin prophylaxis in visual laser ablation of the prostate.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Bacteriuria; Fluoroquinolones; Humans; Laser Therapy | 1994 |
[Efficacy of lomefloxacin in treatment of nonspecific inflammatory diseases and in prophylaxis of postoperative complications in urology].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Female; F | 1998 |
Prevention of urinary tract infection and bacteremia following transurethral surgery: oral lomefloxacin compared to parenteral cefotaxime.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Bacteremia; Cefotaxime; Female; Female Urogenita | 1992 |